Bio

SK Bioscience and IDT Join BARDA–IAVI Bundibugyo Project: Fact-Check and Key Points for the November 5 Q3 IR Call

SK Bioscience: Two-Week Update — Varicella Vaccine Production Suspended, IDT Collaboration Expands, Q3 Results Due November 5

The AI Revolution in the Biotech Industry: From Drug Discovery to Personalized Treatment by 2026

AI can be used to generate and analyze data at multiple stages of drug development. The FDA and EMA principles…

A New Turning Point in Biotechnology Innovation: The 2026 Industry Landscape Shift Driven by AI and Synthetic Biology

In 2026, the biotechnology industry is undergoing unprecedented changes due to the convergence of artificial intelligence and synthetic biology. The…

The Wave of Innovation in Synthetic Biology and Bio-Manufacturing: A New Turning Point for the Biotech Industry in 2026

With the maturation of synthetic biology technology, the bio-manufacturing market is rapidly expanding, forming a new paradigm that replaces traditional…

The AI Revolution in the Biotech Industry: A New Paradigm for Drug Discovery and Personalized Treatment by 2026

As artificial intelligence fundamentally transforms the biotech industry, drug development timelines are halved, and the accuracy of personalized treatments has…

A New Turning Point in the Biotech Revolution: An Analysis of the Biotechnology Industry in 2026 Driven by AI-Based Drug Development and Precision Medicine

As of February 2026, the global biotechnology industry is undergoing one of the most dynamic periods of change in history…

AI Innovation and Market Restructuring in the Biotech Industry: The Ongoing Paradigm Shift in 2026

The fusion of artificial intelligence and biotechnology is revolutionizing the entire biotech industry, from drug development to precision medicine. As…

A New Turning Point in the Biotechnology Industry: Analysis of AI Integration and Personalized Medicine Market Trends in 2026

In 2026, the biotechnology industry is undergoing the most dynamic changes in history, driven by three megatrends: the integration with…

A New Turning Point in Biotech Innovation: The Rapid Growth of AI-Driven Drug Development and Personalized Medicine

By 2026, the biotech industry is experiencing unprecedented growth due to the commercialization of AI-driven drug development and personalized medicine…